| [1] |
Berzigotti A, Dapporto S, Angeloni L, et al. Postprandial splanchnic haemodynamic changes in patients with liver cirrhosis and patent paraumbilical vein[J]. Eur J Gastroenterol Hepatol, 2004, 16(12):1339-1345.
|
| [2] |
Hayashi M, Matsui O, Ueda K, et al. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material[J]. Radiology, 2002, 225(1):143-149.
|
| [3] |
Hsieh MC, Hsu HT, Hsiao PC, et al. Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development[J]. J Clin Lab Anal, 2014, 28(3):237-244.
|
| [4] |
Miles KA. Tumour angiogenesis and its relation to contrast enhancement on computed tomography:a review[J]. Eur J Radiol, 1999, 30(3):198-205.
|
| [5] |
聂东雷，陈亚晗，陆玉敏．肝细胞癌CT表现、病理分级与CD34表达的关系研究[J]．右江医学，2016,44(6):639-642.
|
| [6] |
Lin DX, Zhang QY, Li X, et al. An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus[J]. J Cancer Res Clin Oncol, 2011, 137(1):139-149.
|
| [7] |
黄大庆，曾波，牟忠亮，等．多层螺旋CT灌注成像下肝癌结节血流动力学的改变[J]．实用癌症杂志，2014(10):1304-1306.
|
| [8] |
Wei Y, Yang Q, Zhang Y, et al. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells[J]. Oncotarget, 2017, 8(9):15230-15241.
|
| [9] |
Quiroga S, Sebastià C, Pallisa E, et al. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT[J]. Radiographics, 2001, 21(1):65-81.
|
| [10] |
Villa E, Moles A, Ferretti I, et al. Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival[J]. Hepatology, 2000, 32(2):233-238.
|
| [11] |
Kitao A, Zen Y, Matsui O, et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography-radiologic-pathologic correlation[J]. Radiology, 2009, 252(2):605-614.
|
| [12] |
Ponziani FR, Zocco MA, Campanale C, et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment[J]. World J Gastroenterol, 2010, 16(2):143-155.
|
| [13] |
Liu QS, Mei QL, Li YH. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: safety, efficacy, and prognostic factors[J]. Eur J Radiol, 2017(89):277-283.
|
| [14] |
杨晓辉，彭焱．原发性肝癌并门静脉癌栓的临床治疗进展[J]．现代肿瘤医学，2016,24(23):3863-3867.
|
| [15] |
Fasol U, Frost A, Büchert M, et al. Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis[J]. Ann Oncol, 2012, 23(4):1030-1036.
|
| [16] |
Miyoshi A, Takahashi T, Otsuka T, et al. Efficacy of major hepatectomy for large hepatocellular carcinoma[J]. Hepatogastroenterology, 2009, 56(91/92):768-772.
|
| [17] |
Sun JX, Shi J, Li N, et al. Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma[J]. Cancer Biol Med, 2016, 13(4):452-458.
|
| [18] |
童欢，唐承薇．如何克服肝癌血管介入治疗的弊端？[J]．实用肝脏病杂志，2015,18(3):228-229.
|
| [19] |
Forner A, Gilabert M, Bruix J, et al. Treatment of intermediate-stage hepatocellular carcinoma[J]. Nat Rev Clin Oncol, 2014, 11(9):525-535.
|
| [20] |
Kim DY, Han KH. How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage[J]. Dig Dis, 2012, 30(6):598-602.
|